Emerging and High Growth Companies

Felix Health Inc. in its $10 million Series A financing

Felix Health Inc.
Key Contact
Chad Bayne

Partner, Emerging and High Growth Companies, Toronto

Team
Jeremy Lin

Associate, Emerging and High Growth Companies, Toronto

Michael Grantmyre

Partner, Emerging and High Growth Companies, Calgary

 

On February 16, 2021, Felix Health Inc. (Felix) announced the closing of its $10 million Series A financing round led by Whitecap Venture Partners, with a syndicate group of investors including Mantella Venture Partners, BrandProject and H Ventures. Felix will continue to focus its service in areas of health that people may find sensitive, stigmatized or inaccessible to ultimately become a digital front door that complements and enhances the Canadian healthcare experience. The new round of financing will help support Felix's expansion to Québec and the development of new care offerings for migraines, mental health, HIV prevention and more.

Felix Health Inc. is a patient-driven digital healthcare company empowering people to take control of their health and well-being.

Osler, Hoskin & Harcourt LLP advised Felix Health Inc. with a team consisting of Chad Bayne, Michael Grantmyre, Jeremy Lin and Theresa Donkor (Emerging and High Growth Companies).

Value
$10 million
Date Closed
February 16, 2021
Lead Office
Toronto
Key Contact
Chad Bayne

Partner, Emerging and High Growth Companies, Toronto

Team
Jeremy Lin

Associate, Emerging and High Growth Companies, Toronto

Michael Grantmyre

Partner, Emerging and High Growth Companies, Calgary